Prodromal PD-definition and impact for clinical studies
Professor Daniela Berg is Chair of the Department of Neurology at the Christian-Albrechts-University of Kiel, Germany, and Medical Director of the Clinic of Neurology at the University Hospital of Schleswig-Holstein in Kiel. In 2022 she was elected as Vice-President for the German Neurological Society (DGN). As Chair of the commission of Movement Disorders of the DGN, Board Member of the German Parkinson Society (DPG), Member of the Scientific Advisory Board of the German Parkinson’s Disease Association and Member of the EAN Scientific Panel Movement disorders, she serves at different national and international Boards to promote research in and treatment of Movement Disorders, with a specific focus on Parkinson’s disease.
Her major research interests are the early and differential diagnosis of neurodegenerative disorders, particularly the detection and validation of risk and biomarkers for diagnosis and progression of Parkinson’s disease. The desire to find better, individualized treatment options for those affected by Parkinson’s disease led her to be PI of many clinical studies including conservative approaches. Her scientific contribution to the field can be found in more than 650 peer reviewed manuscripts to which she contributed as author or co-author.
Date: 25 January 2023, 14:00 (Wednesday, 2nd week, Hilary 2023)
Venue: This seminar will be held online. Please email for more details.
Speaker: Dr. Daniela Berg, (University Medical Center Schleswig-Holstein, Germany)
Organising department: Department of Physiology, Anatomy and Genetics (DPAG)
Organiser: Lorraine Dyson (University of Oxford)
Organiser contact email address:
Host: Professor Richard Wade-Martins (Professor of Molecular Neuroscience, University of Oxford)
Part of: OPDC Seminar Series (DPAG)
Booking required?: Not required
Audience: Members of the University only
Editor: Lorraine Dyson